Literature DB >> 26641944

A focus on inflammation as a major risk factor for atherosclerotic cardiovascular diseases.

Ida Gregersen1,2, Sverre Holm1,3, Tuva B Dahl1,2, Bente Halvorsen1,2,4, Pål Aukrust1,2,4,5.   

Abstract

Atherosclerosis is a dynamic, pathogenic process in the artery wall, with potential adverse outcome for the host. Acute events such as myocardial infarction and ischemic stroke often result from rupture of unstable atherosclerotic lesions. Understanding the underlying pathology of such lesions and why and when they rupture, is therefore of great interest for the development of new diagnostics and treatment. Inflammation is one of the key drivers of atherosclerotic plaque development and the interplay between inflammation and lipids constitutes the hallmark of atherosclerotic disease. This review summarizes the role of inflammation in atherosclerosis and presents some of the latest discoveries as well as unmet needs regarding the role of inflammation as major risk factor in atherosclerotic disease.

Entities:  

Keywords:  Atherosclerosis; T cells; cytokines; inflammation; monocytes

Mesh:

Year:  2015        PMID: 26641944     DOI: 10.1586/14779072.2016.1128828

Source DB:  PubMed          Journal:  Expert Rev Cardiovasc Ther        ISSN: 1477-9072


  16 in total

1.  Gene expression profiling of coronary artery disease and its relation with different severities.

Authors:  Shiridhar Kashyap; Sudeep Kumar; Vikas Agarwal; Durga P Misra; Shubha R Phadke; Aditya Kapoor
Journal:  J Genet       Date:  2018-09       Impact factor: 1.166

Review 2.  Role of circulating factors in cardiac aging.

Authors:  Antonio Cannatà; Gabriella Marcon; Giovanni Cimmino; Luca Camparini; Giulio Ciucci; Gianfranco Sinagra; Francesco S Loffredo
Journal:  J Thorac Dis       Date:  2017-03       Impact factor: 2.895

Review 3.  Vaccination against atherosclerosis.

Authors:  Kouji Kobiyama; Ryosuke Saigusa; Klaus Ley
Journal:  Curr Opin Immunol       Date:  2019-03-29       Impact factor: 7.486

4.  Enhanced responsiveness of platelets to vicagrel in IL-10-deficient mice through STAT3-dependent up-regulation of the hydrolase arylacetamide deacetylase in the intestine.

Authors:  Yu-Meng Jia; Huan Zhou; Ting Tai; Tong-Tong Gu; Jin-Zi Ji; Qiong-Yu Mi; Bei-Bei Huang; Yi-Fei Li; Ting Zhu; Hong-Guang Xie
Journal:  Br J Pharmacol       Date:  2019-04-21       Impact factor: 8.739

5.  Macrophage-Specific IGF-1 Overexpression Reduces CXCL12 Chemokine Levels and Suppresses Atherosclerotic Burden in Apoe-Deficient Mice.

Authors:  Patricia Snarski; Sergiy Sukhanov; Tadashi Yoshida; Yusuke Higashi; Svitlana Danchuk; Bysani Chandrasekar; Di Tian; Vikara Rivera-Lopez; Patrick Delafontaine
Journal:  Arterioscler Thromb Vasc Biol       Date:  2021-12-02       Impact factor: 8.311

6.  Combined Shikonin-Loaded MPEG-PCL Micelles Inhibits Effective Transition of Endothelial-to-Mesenchymal Cells.

Authors:  Guanglin Li; Chenxu Shang; Qingqing Li; Lifang Chen; Zejun Yue; Lingxuan Ren; Jianjun Yang; Jiye Zhang; Weirong Wang
Journal:  Int J Nanomedicine       Date:  2022-09-24

Review 7.  Fundamental role of pan-inflammation and oxidative-nitrosative pathways in neuropathogenesis of Alzheimer's disease in focal cerebral ischemic rats.

Authors:  Mak Adam Daulatzai
Journal:  Am J Neurodegener Dis       Date:  2016-06-01

8.  A clinically applicable adjuvant for an atherosclerosis vaccine in mice.

Authors:  Kouji Kobiyama; Melanie Vassallo; Jessica Mitzi; Holger Winkels; Hong Pei; Takayuki Kimura; Jacqueline Miller; Dennis Wolf; Klaus Ley
Journal:  Eur J Immunol       Date:  2018-08-12       Impact factor: 5.532

Review 9.  Fundamental role of pan-inflammation and oxidative-nitrosative pathways in neuropathogenesis of Alzheimer's disease.

Authors:  Mak Adam Daulatzai
Journal:  Am J Neurodegener Dis       Date:  2016-03-01

Review 10.  Age-related small vessel disease: a potential contributor to neurodegeneration in multiple sclerosis.

Authors:  Ruth Geraldes; Margaret M Esiri; Gabriele C DeLuca; Jacqueline Palace
Journal:  Brain Pathol       Date:  2017-03-12       Impact factor: 6.508

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.